Cygna Labs Corp. entered into a definitive agreement to acquire DDI business of NCC Group from NCC Group plc (LSE:NCC) on December 31, 2022. The acquisition includes the purchase of the DDI Guard product, the portfolio of DDI customers, and NCC Group?s team of DDI experts. The team from NCC will become part of the N3K team, a wholly-owned subsidiary of Cygna Labs Group. Christoph Naumann, Sarah Shaw ,Charles Jemmett ,Sahira Khwaja, Laura Alvarez Otero, Andrea Constantine ,Ed Bowyer, Nicola Fulford, Elliot Weston, Suyong Kim, Claire Southern, Liam Naidoo, Olga Tocewicz, Jesus Garcia Sanchez of Hogan Lovells acted as the legal advisors and Grant Thornton Corporate Finance, LLC acted as the financial advisor to Cygna Labs. goetzpartners securities Limited acted as financial advisor to Cygna Labs Corp. Cygna Labs was advised Marsh on insurance and King & Wood Mallesons financing matters.

Cygna Labs Corp completed the acquisition of DDI business of NCC Group from NCC Group plc (LSE:NCC) for £5.8 million on December 31, 2022. The consideration of £5.8 million, of which £2.0 million was satisfied in cash and the remaining £3.8 million is contingent on novation of certain customer contracts and £2 million has been received post year end and it is expected that the remaining proceeds will be received in FY24.